Indiana CTSI Task Force on Diversity, Inclusion and Health Equity |
The Indiana CTSI co-directors have established a Task Force on Diversity, Inclusion and Health Equity at IU School of Medicine. The group is establishing a framework to evaluate programs that enhance diversity and inclusion in both leadership and research endeavors.
The taskforce is led by Brownsyne Tucker Edmonds, MD, director of diversity and inclusion and Sylk M. Sotto, EdD, vice chair for faculty affairs, development, and diversity in the Department of Medicine at Indiana University School of Medicine. Read how Dr. Edmonds Tucker was recently honored for her work to eliminate disparities in medicine.
|
Subscribe to Indiana CTSI News |
Stay Up to Date on the Latest Opportunities & Information!
The Indiana CTSI has experts across a wide variety of fields and research areas of interest. Click the links below to have the latest research discoveries and developments making news and positively impacting health in Indiana delivered right to your inbox.
|
|
|
2023 Indiana CTSI Annual Meeting |
September 22, 2023
9:00 a.m. – 3:30 p.m.
|
The 2023 Indiana Clinical and Translational Sciences Institute (CTSI) Annual Meeting will be on Friday, September 22, 2023. The keynote speaker will be Huda Y. Zoghbi, MD, who is also this year’s winner of the August M. Watanabe Prize in Translational Research. The 2023 Indiana CTSI Annual Meeting will be focused on neurological disorders.
|
|
|
Community Health Partnerships (CHeP) Trailblazer Planning Grant |
Submission Deadline: August 1, 2023
|
The Indiana CTSI Community Health Partnerships is soliciting proposals for the development of community-university partnerships to improve health, examine social determinants of health, or enhance health equity to result in future collaborative research proposals. The award can be used to establish new partnerships or to strengthen/expand existing community-university partnerships to solve critical health problems affecting Indiana residents. This award will not fund research pilot projects; instead, it will fund activities that help develop partnerships between organizations that have potential to later engage in joint research projects to address health, health equity or social determinants of health. The expected outcome of this award is the development of a future research proposal for opportunities such as the Community Health Partnerships Trailblazer Award. Examples of partnership development activities we are interested in funding include meetings, conferences, travel expenses, and quality improvement assessments.
Awards will be up to $5,000 for one year to allow for partnership growth and collaborative grant proposal development.
Contact Information: chep@iupui.edu
|
|
|
IUSCCC “Near-Miss” NIH R01 Initiative |
The IU Simon Comprehensive Cancer Center (IUSCCC) is providing an opportunity to fund cancer focused PI-directed applications to the National Institutes of Health that have been reviewed once and missed the NIH pay line and have a high potential for obtaining external funding. The goal is to increase the cancer focused NIH funding base in the IUSCCC. Non-NCI targeted applications should have significant cancer relevance.
Investigators wishing to apply to this funding mechanism must first submit a draft cover letter (letter of intent) for approval by the IUSCCC Executive Committee before working with a Coordinator to submit a full application. Once approved, the link for submitting the online application will be sent.
Maximum allowable amount for R01, R42 and R44 grants is $50K with P01 and SPORE funding amounts evaluated on a case-by-case basis. .
Contact for Letter of Intent and Questions: Kaitlin Condron or Crystal Baker
|
|
|
DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards |
Submission Deadline: July 3, 2023
|
The IU School of Medicine Department of Pediatrics is a member of the multi-institutional Developmental and Hyperactive Ras Tumor (DHART) SPORE program. The goal of the SPORE program is to improve the diagnosis and management of tumors arising in persons with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes through basic, translational, and clinical research.
IU investigators who lead the DHART SPORE program conduct their research within the Herman B Wells Center for Pediatric Research, a national leader in childhood disease research. To learn more about the DHART SPORE program, including its cores, ongoing projects and overall approach, visit dhartspore.org.
Two funding opportunities are available via this program: the Developmental Research Program (DRP) and the Career Enhancement Program (CEP).
Awards: Funding is available for one or two DRP projects at $50,000 - $75,000 AND two to three CEP projects at $50,000 - $75,000. Awards will be for a 12-month period.
Eligibility: Proposals are accepted from clinical or basic science investigators at any DHART SPORE institution as well as from other academic institutions. See guidelines for additional eligibility criteria
Contact Information: Kevin Shannon or Jaishiri Blakeley
|
|
|
Alzheimer’s Disease Pre-clinical Translational Science Grant |
Submission Deadline: July 10, 2023
|
Description: This funding opportunity announcement invites applications from all CTSI investigators with a full-time academic appointment for up to $50,000 to support innovative research work that is in scope and aligned with the research activities of the IUSM-Purdue TREAT-AD Center. These include (but are not limited to):
|
- Bioinformatic analyses and drug target hypothesis generation within neuroinflammatory pathways
-
Target validation studies for proposed drug targets
- Innovative chemical biology and cellular pharmacology studies for proposed targets that provide insights to disease initiation and progression
- Structural biology or biophysical studies on proteins proposed as drug targets
- De-novo drug design approaches for proposed targets
- Novel PET ligands and supporting CSF biomarkers for preclinical studies and clinical trials, etc.
|
Contact Information: Alan D. Palkowitz, Director for the IUSM-Purdue TREAT-AD Center apalkow@iu.edu
|
|
|
If you have any questions about Indiana CTSI grants, programs, or upcoming events please feel free to reach out to co-navigators Jessica Brookshire or Paul Helquist.
|
|
|
The Indiana CTSI includes Indiana University, Purdue University, and the University of Notre Dame as the major academic partners along with a number of other institutions and entities in the state.
It is funded by a Clinical and Translational Sciences Award from the National Institutes of Health amounting to some $38 million for the current seven-year funding period of 2023-2030. This funding is supplemented by additional support from many other institutional and corporate partners.
Funding is provided to researchers by many mechanisms to promote translational and collaborative research among the partner institutions.
For more information, please visit: indianactsi.org
|
| |
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
317 Main Building | Notre Dame, IN 46556 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|